MiMedx Group
MDXG · NASDAQ
$4.23−$0.15 (−3.42%)TodayMarket closed ·
Prev close $4.38
About MDXG
- Employees
- 808
- Headquarters
- Marietta, Georgia
- Listed
- Aug 20, 2007
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- mimedx.com
Leadership
| Name | Title | Since |
|---|---|---|
| M. Kathleen Behrens Wilsey | — | — |
| Joseph Capper | — | 2023 |
| Douglas Rice | — | — |
| Ricci Whitlow | — | — |
| William Hulse | — | — |
| Kimberly Maersk-Moller | — | — |
| James Bierman | — | — |
| William Hawkins | — | — |
| Cato Laurencin | — | — |
| K. Todd Newton | — | 2019 |
| Tiffany Olson | — | — |
| Dorothy Puhy | — | — |
| Martin Sutter | — | — |
| Matt Notarianni | — | 2023 |
Revenue by product and region
Fiscal year ended Dec 31, 2025: $418.63M total revenue
By product
- Wound$276.33M66.0%
- Surgical$142.30M34.0%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| United States | Customer | — |
| Essex Woodlands Management, Inc. | Supplier and customer | — |
| Wake Forest Institute for Regenerative Medicine | Supplier and customer | — |
Similar companies
Companies in the same industry as MiMedx Group
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.